Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
Int J Med Sci ; 18(3): 835-845, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33437220

RESUMO

Chemotherapy and radiotherapy are the most frequent treatment for patients suffering from malignant progression of cancer. Even though new treatments are now being implemented, administration of these chemotherapeutic agents remains as the first line option in many tumor types. However, the secondary effects of these compounds represent one of the main reasons cancer patients lose life quality during disease progression. Recent data suggests that Ocoxin, a plant extract and natural compound based nutritional complement rich in antioxidants and anti-inflammatory mediators exerts a positive effect in patients receiving chemotherapy and radiotherapy. This mixture attenuates the chemotherapy and radiotherapy-related side effects such as radiation-induced skin burns and mucositis, chemotherapy-related diarrhea, hepatic toxicity and blood-infection. Moreover, it has been proven to be effective as anticancer agent in different tumor models both in vitro and in vivo, potentiating the cytotoxic effect of several chemotherapy compounds such as Lapatinib, Gemcitabine, Paclitaxel, Sorafenib and Irinotecan. The aim of this review is to put some light on the potential of this nutritional mixture as an anticancer agent and complement for the standard chemotherapy routine.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Ácido Ascórbico/administração & dosagem , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Ácido Fólico/administração & dosagem , Neoplasias/terapia , Ácido Pantotênico/administração & dosagem , Extratos Vegetais/administração & dosagem , Lesões por Radiação/prevenção & controle , Vitamina B 12/administração & dosagem , Vitamina B 6/administração & dosagem , Sulfato de Zinco/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/farmacocinética , Ácido Ascórbico/farmacocinética , Quimiorradioterapia/efeitos adversos , Quimiorradioterapia/métodos , Ensaios Clínicos como Assunto , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Sinergismo Farmacológico , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Ácido Fólico/farmacocinética , Humanos , Ácido Pantotênico/farmacocinética , Extratos Vegetais/farmacocinética , Lesões por Radiação/etiologia , Tolerância a Radiação/efeitos dos fármacos , Resultado do Tratamento , Vitamina B 12/farmacocinética , Vitamina B 6/farmacocinética , Sulfato de Zinco/farmacocinética
2.
J Exp Bot ; 69(18): 4469-4481, 2018 08 14.
Artigo em Inglês | MEDLINE | ID: mdl-29931117

RESUMO

Foliar application of zinc (Zn) to crops is an effective way to increase the grain concentration of Zn. However, the development of more efficient foliar Zn fertilizers is limited by a lack of knowledge regarding the distribution, mobility, and speciation of Zn in leaves once it is taken up by the plant. We performed an experiment using radiolabelled Zn (65Zn), and in situ time-resolved elemental imaging using synchrotron X-ray fluorescence microscopy (XFM), to investigate the behaviour of two commonly used Zn foliar fertilizers (Zn sulphate and ZnEDTA) in wheat (Triticum aestivum) leaves. Both experiments showed that Zn had limited mobility in leaves, moving <25 mm from the application point after 24 h. Although limited, the translocation of Zn occurred quickly for both treatments; moving more between 3 h and 12 h after application than between 12 h and 24 h. Speciation analysis using synchrotron-based X-ray absorption near-edge structure (XANES) showed that ZnEDTA was in fact taken up in chelated form and not as ionic Zn (Zn2+). The XANES data also showed that Zn, from both treatments, was then complexed by ligands in the leaf (e.g. phytate and citrate), potentially in response to localized Zn toxicity. The results of the present study provide important insights into the behaviour of commonly used foliar-applied Zn fertilizers, and can be used to optimize current fertilization strategies and contribute to the development of more efficient foliar Zn fertilizers.


Assuntos
Ácido Edético/farmacocinética , Fertilizantes/análise , Folhas de Planta/metabolismo , Triticum/efeitos dos fármacos , Sulfato de Zinco/farmacocinética , Zinco/farmacocinética , Transporte Biológico , Grão Comestível/química , Grão Comestível/efeitos dos fármacos , Folhas de Planta/efeitos dos fármacos , Triticum/metabolismo , Espectroscopia por Absorção de Raios X
3.
J Nutr ; 146(1): 76-80, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26674764

RESUMO

BACKGROUND: Biofortification of staple food crops is a promising strategy to combat zinc deficiency, and it is of particular interest for rice and crops that are not consumed as flours and therefore not suitable for postharvest fortification. Because zinc absorption is decreased by phytic acid (PA) and perhaps other dietary components, it is important to measure the absorption of zinc from a biofortified crop before determining its efficacy. OBJECTIVE: In this study, we compared the zinc absorption from zinc-biofortified rice (hydroponically enriched with (70)Zn) with that from a control rice of the same variety fortified with (70)ZnSO4 at point of use to reach the same total zinc content of 1.1 mg/meal. Both rice meals had a PA:Zn molar ratio of 12. METHODS: Fractional absorption of zinc (FAZ) was measured with the use of the double-isotope tracer ratio method in 16 apparently healthy adults [18-45 y old; BMI (in kg/m(2)) 19-25] who consumed 2 single meals at 4-wk intervals in random order in a crossover design. RESULTS: The FAZ from the biofortified rice (mean ± SD: 25.1 ± 8.7%) did not differ significantly from that of the point-of-use fortified rice (mean ± SD: 20.8 ± 7.1%) (P = 0.08). CONCLUSIONS: These results suggest that the native zinc accumulated in the biofortified rice was readily released from the rice matrix and that its absorption by adults was influenced by PA and other food components in a similar way to the inorganic zinc compound added to the rice at point of use. Moreover, rice biofortification is likely to be as good as postharvest zinc fortification as an intervention strategy to combat zinc deficiency. This trial was registered at clinicaltrials.gov as NCT01633450.


Assuntos
Alimentos Fortificados , Sulfato de Zinco/farmacocinética , Zinco/farmacocinética , Adolescente , Adulto , Disponibilidade Biológica , Índice de Massa Corporal , Grão Comestível/química , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oryza/química , Ácido Fítico , Adulto Jovem , Zinco/administração & dosagem , Zinco/deficiência , Sulfato de Zinco/administração & dosagem
4.
Biometals ; 27(3): 495-505, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24619814

RESUMO

The normal human prostate accumulates the highest levels of zinc (Zn) of any soft tissue in the body. The pool of zinc available to the body is known to significantly decrease with age. It is suggested that dietary Zn supplementation protects against oxidative damage and reduces the risk of cancer. Zinc sulfate and zinc gluconate were the most frequently mentioned in per os administration in studies on Zn supplementation. The major aim of the study was to compare the bioavailability of different Zn compounds (sulfate, gluconate and citrate) in the prostate after their daily administration to male rats at three different doses (3.0; 15.0; and 50.0 mg Zn/kg b.w.) for 30 days. The results show that bioavailability in the prostate differs significantly between individual zinc preparations. A significantly elevated Zn concentration in the dorso-lateral lobe of the prostate, compared to controls, was found in the rats supplemented with two compounds only: zinc gluconate and zinc citrate. However, after administration of zinc gluconate, this effect occurred even at the lowest dose. The lowest zinc bioavailability in the prostate was found in the rats administered zinc sulfate: no significant Zn increase was seen in particular zones of the prostate. To sum up, the use of zinc gluconate is worth considering as a possible means of zinc supplementation in men.


Assuntos
Ácido Cítrico/farmacocinética , Suplementos Nutricionais , Gluconatos/farmacocinética , Próstata/metabolismo , Sulfato de Zinco/farmacocinética , Animais , Disponibilidade Biológica , Ácido Cítrico/administração & dosagem , Cobre/metabolismo , Gluconatos/administração & dosagem , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Humanos , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Malondialdeído/metabolismo , Próstata/efeitos dos fármacos , Ratos Wistar , Superóxido Dismutase/metabolismo , Aumento de Peso/efeitos dos fármacos , Sulfato de Zinco/administração & dosagem
5.
Inhal Toxicol ; 26(3): 193-206, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24517842

RESUMO

CONTEXT: Inhaled hygroscopic aerosols will absorb water vapor from the warm and humid air of the human lung, thus growing in size and consequently changing their deposition properties. OBJECTIVE: The objectives of the present study are to study the effect of a stochastic lung structure on individual particle growth and related deposition patterns and to predict local deposition patterns for different hygroscopic aerosols. MATERIALS AND METHODS: The hygroscopic particle growth model proposed by Ferron et al. has been implemented into the stochastic asymmetric lung deposition model IDEAL. Deposition patterns were calculated for sodium chloride (NaCl), cobalt chloride (CoCl2 · 6H2O), and zinc sulfate (ZnSO4 · 7H2O) aerosols, representing high, medium and low hygroscopic growth factors. RESULTS: Hygroscopic growth decreases deposition of submicron particles compared to hydrophobic particles with equivalent diameters due to a less efficient diffusion mechanism, while the more efficient impaction and sedimentation mechanisms increase total deposition for micron-sized particles. Due to the variability and asymmetry of the human airway system, individual trajectories of inhaled particles are associated with individual growth factors, thereby enhancing the variability of the resulting deposition patterns. DISCUSSION AND CONCLUSIONS: Comparisons of model predictions with several experimental data for ultrafine and micrometer-sized particles indicate good agreement, considering intersubject variations of morphometric parameters as well as differences between experimental conditions and modeling assumptions.


Assuntos
Poluentes Atmosféricos/farmacocinética , Exposição por Inalação/análise , Pulmão/metabolismo , Modelos Biológicos , Material Particulado/farmacocinética , Absorção , Aerossóis , Poluentes Atmosféricos/toxicidade , Cobalto/farmacocinética , Cobalto/toxicidade , Humanos , Pulmão/efeitos dos fármacos , Material Particulado/toxicidade , Cloreto de Sódio/farmacocinética , Cloreto de Sódio/toxicidade , Processos Estocásticos , Distribuição Tecidual , Água/química , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/toxicidade
6.
ScientificWorldJournal ; 2014: 217142, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25215316

RESUMO

Zinc-enriched yeast (ZnY) and zinc sulfate (ZnSO4) are considered zinc (Zn) supplements currently available. The purpose of the investigation was to compare and evaluate pharmacokinetics and biodistribution of ZnY and ZnSO4 in rats. ZnY or ZnSO4 were orally administered to rats at a single dose of 4 mg Zn/kg and Zn levels in plasma and various tissues were determined using inductively coupled plasma-optical emission spectrometry. Maximum plasma concentration values were 3.87 and 2.81 µg/mL for ZnY and ZnSO4, respectively. Both ZnY and ZnSO4 were slowly eliminated with a half-life of over 7 h and bone had the highest Zn level in all tissues. Compared to ZnSO4, the relative bioavailability of ZnY was 138.4%, indicating that ZnY had a significantly higher bioavailability than ZnSO4.


Assuntos
Suplementos Nutricionais , Sulfato de Zinco/farmacocinética , Zinco/farmacocinética , Ração Animal , Animais , Ratos , Distribuição Tecidual , Zinco/administração & dosagem , Óxido de Zinco/administração & dosagem , Óxido de Zinco/farmacocinética , Sulfato de Zinco/administração & dosagem
7.
J Sci Food Agric ; 94(14): 3053-60, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24638829

RESUMO

BACKGROUND: Soybean sprouts are a very popular vegetable in Southeast Asian countries and regions. Zinc-rich soybean sprouts can help to improve Zn deficiency in humans. The aim of this study was to prepare Zn-enriched soybean sprouts through agronomic biofortification (germination with ZnSO4 solution) in order to provide consumers with a dietary material for Zn supplementation. RESULTS: A suitable Zn concentration in ZnSO4 solution used for cultivation of Zn-enriched soybean sprouts was found to be less than or equal to 20 µg mL(-1) . Upon biofortification with 10 and 20 µg Zn mL(-1) ZnSO4 solutions, Zn content (102 and 163 vs 32 mg kg(-1) dry weight (DW)), bioaccessible Zn content (3.86 and 8.53 vs 1.11 mg kg(-1) DW) and Zn bioaccessibility (3.8 and 5.2 vs 3.5%) in edible portions of Zn-enriched soybean sprouts were significantly enhanced compared with those of water-germinated soybean sprouts. Meanwhile, no significant differences were observed in Fe, Mn and Cu contents of edible portions of soybean sprouts between ZnSO4 solution and water germinations, although soaking leakages of minerals (Fe, Mn and Cu) from soybean seeds to steeping media occurred to some degree. CONCLUSION: Soybean sprouts biofortified with ZnSO4 solution at 10 or 20 µg Zn mL(-1) contained appreciable quantities of Zn and had good Zn bioaccessibility, indicating that Zn-enriched soybean sprouts may serve as a suitable dietary Zn source to improve the Zn intake of Zn-deficient populations.


Assuntos
Glycine max/química , Sulfato de Zinco/química , Sulfato de Zinco/farmacocinética , Disponibilidade Biológica , Análise de Alimentos , Alimentos Fortificados
8.
J Pharm Pharm Sci ; 16(5): 848-67, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24393559

RESUMO

PURPOSE: Accumulating evidences suggest a critical role of trace metal dyshemostasis in oxidative stress and cardiac dysfunction after myocardial infarction (MI). This study investigated the cardioprotective effects of selenium yeast (Se), chromium picolinate Cr(pic)3, zinc sulfate (Zn) and their combination on isoproterenol (ISO)-induced MI. METHODS: Rats were divided into six groups: normal control, ISO control, Se-pretreated (0.1 mg/kg), Cr(pic)3-pretreated (400 µg/kg), Zn-pretreated (30 mg/kg) and metal combination-pretreated groups. All metals were administered for 28 days and at the 27th day, MI was induced by subcutaneous injection of ISO (85 mg/kg) once for two consecutive days. RESULTS: ISO control group showed hyperlipidemia, elevation of cardiac biomarkers and lipid peroxidation and increased immunostaining of p47 phox NADPH oxidase subunit in addition to decreased levels of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Cardiac levels of tumor necrosis factor-α (TNF-α) were increased, while vascular endothelial growth factor (VEGF, the major angiogenic factor) was decreased. Pretreatment with Se normalized the cardiac enzymes, lipid peroxidation, GSH, SOD, CAT, GPx, TNF-α and VEGF (P<0.001) and reduced the immunostaining of p47 phox subunit. However, Se failed to correct the dyslipidemia. Cr(pic)3 significantly improved lipid profile (P<0.001) and all other biochemical deviations except for VEGF. Zn, but to lesser extent, reduced the oxidative damage and TNF-α levels and improved both dyslipidemia and angiogenesis. Combination therapy exhibited less prominent protection compared to individual metals. CONCLUSION: Daily supplementation with trace metals is promising for improving myocardial performance via preventing oxidative damage, induction of angiogenesis, anti-inflammatory and/or anti-hyperlipidemic mechanisms.


Assuntos
Cardiotônicos/uso terapêutico , Infarto do Miocárdio/tratamento farmacológico , Ácidos Picolínicos/uso terapêutico , Selênio/uso terapêutico , Sulfato de Zinco/uso terapêutico , Animais , Aterosclerose/prevenção & controle , Cardiotônicos/sangue , Cardiotônicos/farmacocinética , Quimioterapia Combinada , Dislipidemias/tratamento farmacológico , Dislipidemias/metabolismo , Dislipidemias/patologia , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Inflamação/patologia , Isoproterenol , Masculino , Infarto do Miocárdio/induzido quimicamente , Infarto do Miocárdio/metabolismo , Infarto do Miocárdio/patologia , Miocárdio/metabolismo , Miocárdio/patologia , NADPH Oxidases/metabolismo , Neovascularização Fisiológica/fisiologia , Estresse Oxidativo/efeitos dos fármacos , Ácidos Picolínicos/sangue , Ácidos Picolínicos/farmacocinética , Ratos , Ratos Wistar , Saccharomyces cerevisiae , Selênio/sangue , Selênio/farmacocinética , Sulfato de Zinco/sangue , Sulfato de Zinco/farmacocinética
9.
Nutr Cancer ; 63(2): 212-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21207320

RESUMO

The present study was conducted to evaluate the kinetics of zinc utilization during the formation of colon carcinoma in an animal model of colon carcinogenesis. The rats were segregated into 4 groups: untreated control, 1,2-dimethylhydrazine (DMH) treated, zinc treated, and DMH+zinc treated. Colon carcinogenesis was initiated through weekly subcutaneous injections of DMH (30 mg/kg body weight) for 8 wk. Zinc (in the form of zinc sulphate) was supplemented at a dose level of 227 mg/L in drinking water, ad libitum for the entire duration of study. Whole body (65)Zn kinetics followed two-compartment kinetics, with Tb(1) representing the initial fast component of the biological half-life and Tb(2), the slower component. The Tb(1) component showed a significant elevation while the Tb(2) component was significantly diminished in DMH-treated rats, which, however, got normalized following zinc supplementation. The biodistribution and subcellular distribution of (65)Zn was significantly affected in DMH-treated rats when compared to normal control rats. However, zinc significantly reversed the altered (65)Zn uptake in different organs and various fractions of colon. The present study for the first time demonstrated a faster mobilization of zinc during initiation of experimentally induced colon carcinoma and provides a physiological basis for the role of zinc in colon tumorigenesis.


Assuntos
Neoplasias do Colo/induzido quimicamente , Suplementos Nutricionais , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/farmacocinética , 1,2-Dimetilidrazina/toxicidade , Animais , Carcinógenos/toxicidade , Colo/patologia , Meia-Vida , Masculino , Ratos , Ratos Sprague-Dawley , Distribuição Tecidual , Radioisótopos de Zinco/farmacocinética
10.
Vopr Pitan ; 80(5): 39-44, 2011.
Artigo em Russo | MEDLINE | ID: mdl-22238947

RESUMO

In experiments on rats there was researched bioavailability of zinc oxide (ZnO) nanoparticles. There were determined the content of Zn in blood serum and tibia, intestinal uptake of macromolecules of egg albumin, some hematological, biochemical and immune indices, liver cells apoptosis. The results obtained show that the uptake of nanoparticles of ZnO enables restoration of this microelement status damaged by zinc deficit diet.


Assuntos
Suplementos Nutricionais , Nanopartículas , Óxido de Zinco/farmacologia , Animais , Apoptose/efeitos dos fármacos , Disponibilidade Biológica , Peso Corporal/efeitos dos fármacos , Hepatócitos/efeitos dos fármacos , Imunidade Celular/efeitos dos fármacos , Dose Letal Mediana , Leucócitos/citologia , Leucócitos/efeitos dos fármacos , Masculino , Tamanho do Órgão/efeitos dos fármacos , Tamanho da Partícula , Ratos , Ratos Wistar , Zinco/deficiência , Óxido de Zinco/administração & dosagem , Óxido de Zinco/farmacocinética , Óxido de Zinco/toxicidade , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/farmacologia , Sulfato de Zinco/toxicidade
11.
Br J Nutr ; 103(7): 1015-22, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19889243

RESUMO

The Thriposha programme is a community-level nutrition intervention in Sri Lanka that provides a combination of energy, protein and micronutrients as a 'ready-to-eat' cereal-based food. We measured the bioavailability of Fe and Zn from Thriposha formula at two different molar ratios of Zn:Fe in order to determine the effect on Fe and Zn absorption. Children 4-7 years (n 53) were given a meal prepared with 50 g Thriposha containing 1.5 mg Zn as zinc sulphate and either 9 mg (high Fe concentration (HiFe)) or 4.5 mg (low Fe concentration (LoFe)) Fe as ferrous fumarate. Zn and Fe percent absorption were measured using stable isotopes by tracer:tracee ratio and by incorporation of erythrocytes, respectively. Percent Fe absorption from the two meals was similar (6.6 % (4.8) v. 4.8 % (2.6); P = 0.15), but total Fe absorption was significantly higher from the HiFe meal (0.59 (0.43) mg) than the LoFe meal (0.20 (0.12) mg; P = 0.01). There was no significant difference between the two groups in Zn absorption (10.7 % (0.9) v. 8.8 % (1.4), P = 0.13, respectively). Decreasing the amount of Fe in Thriposha did not cause a significant change in the percent absorption of Fe and Zn, but significantly lowered the total amount of absorbed Fe. These results demonstrate the utility of maintaining a higher Fe content in this supplement. Further studies to increase Zn content are warranted while maintaining a HiFe.


Assuntos
Suplementos Nutricionais , Grão Comestível , Eritrócitos/metabolismo , Compostos Ferrosos/administração & dosagem , Oligoelementos/farmacocinética , Sulfato de Zinco/administração & dosagem , Disponibilidade Biológica , Criança , Pré-Escolar , Dieta , Feminino , Compostos Ferrosos/farmacocinética , Humanos , Absorção Intestinal , Isótopos , Masculino , Sri Lanka , Oligoelementos/administração & dosagem , Oligoelementos/sangue , Sulfato de Zinco/farmacocinética
12.
Menopause ; 27(2): 143-149, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31613827

RESUMO

OBJECTIVE: To test the biocompatibility of a zinc-containing vaginal gel, evaluate its ability to release zinc, and to assess the transepithelial permeability of zinc on human vaginal epithelium. METHODS: The release and membrane diffusion of zinc from the vaginal gel was tested by a vertical Franz-diffusion cell system. The biocompatibility of the gel was tested on HaCaT cells and reconstructed human vaginal epithelium. MTT assay was used to detect cell viability. Lactate dehydrogenase (LDH) assay was used to access cytotoxicity. The permeability of zinc was tested on the reconstructed human vaginal epithelium. The integrity of the reconstructed human vaginal epithelium after the permeability experiments was measured by transepithelial electric resistance. Zinc levels were determined by inductively coupled plasma optical emission spectrometry. RESULTS: 20 µM zinc sulfate did not decrease cell viability during the 24 and 72-hour treatment. Similarly, cell viability did not decrease significantly after 60 minutes of incubation with the gel and no toxic compound released from the vaginal gel during the 120 minutes diffusion experiment. A total of 72-hour exposure to the zinc-containing vaginal gel showed no cytotoxicity using LDH assay. Using cellulose-acetate membranes, 24.6% of the zinc content of the gel was released and appeared in the acceptor phase after 15 minutes. Zinc had high permeability (2.2 ±â€Š0.8 × 10 cm/s) from the vaginal gel on reconstructed human vaginal epithelium. CONCLUSIONS: The zinc-containing (20 µM) vaginal gel was not toxic. The release of zinc is rapid from the vaginal gel. Zinc permeated rapidly through the vaginal epithelial cell layers.


Assuntos
Sobrevivência Celular/efeitos dos fármacos , Permeabilidade/efeitos dos fármacos , Cremes, Espumas e Géis Vaginais/farmacocinética , Sulfato de Zinco/farmacocinética , Disponibilidade Biológica , Epitélio/efeitos dos fármacos , Feminino , Humanos , Teste de Materiais , Modelos Anatômicos , Vagina/efeitos dos fármacos
13.
Nanotheranostics ; 4(3): 173-183, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32483522

RESUMO

Indium phosphide/zinc sulfate (InP/ZnS) quantum dots (QDs) are presumed to be less hazardous than those that contain cadmium. However, the toxicological profile has not been established. The present study investigated the acute toxicity of InP/ZnS QDs with different surface modifications (COOH, NH2, and OH) in mice after pulmonary aerosol inhalation. InP/ZnS QDs were able to pass through the blood-gas barrier and enter the circulation, and subsequently accumulated in major organs. No obvious changes were observed in the body weight or major organ coefficients. Red blood cell counts and platelet-related indicators were in the normal range, but the proportion of white blood cells was altered. The InP/ZnS QDs caused varying degrees of changes in some serum markers, but no histopathological abnormalities related to InP/ZnS QDs treatment was observed in major organs except that hyperemia in alveolar septa was found in lung sections. These results suggested that the effects of respiratory exposure to InP/ZnS QDs on the lungs need to be fully considered in future biomedical application although the overall toxicity of quantum dots is relatively low.


Assuntos
Pulmão , Pontos Quânticos , Administração por Inalação , Animais , Peso Corporal/efeitos dos fármacos , Feminino , Índio/administração & dosagem , Índio/farmacocinética , Índio/toxicidade , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Camundongos , Camundongos Endogâmicos BALB C , Microscopia de Fluorescência , Fosfinas/administração & dosagem , Fosfinas/farmacocinética , Fosfinas/toxicidade , Pontos Quânticos/administração & dosagem , Pontos Quânticos/análise , Pontos Quânticos/metabolismo , Pontos Quânticos/toxicidade , Propriedades de Superfície , Distribuição Tecidual , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/toxicidade
14.
J Trace Elem Med Biol ; 55: 44-49, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31345364

RESUMO

While the underlying mechanisms of Parkinson's disease (PD) are still insufficiently studied, a complex interaction between genetic and environmental factors is emphasized. Nevertheless, the role of the essential trace element zinc (Zn) in this regard remains controversial. In this study we altered Zn balance within PD models of the versatile model organism Caenorhabditis elegans (C. elegans) in order to examine whether a genetic predisposition in selected genes with relevance for PD affects Zn homeostasis. Protein-bound and labile Zn species act in various areas, such as enzymatic catalysis, protein stabilization pathways and cell signaling. Therefore, total Zn and labile Zn were quantitatively determined in living nematodes as individual biomarkers of Zn uptake and bioavailability with inductively coupled plasma tandem mass spectrometry (ICP-MS/MS) or a multi-well method using the fluorescent probe ZinPyr-1. Young and middle-aged deletion mutants of catp-6 and pdr-1, which are orthologues of mammalian ATP13A2 (PARK9) and parkin (PARK2), showed altered Zn homeostasis following Zn exposure compared to wildtype worms. Furthermore, age-specific differences in Zn uptake were observed in wildtype worms for total as well as labile Zn species. These data emphasize the importance of differentiation between Zn species as meaningful biomarkers of Zn uptake as well as the need for further studies investigating the role of dysregulated Zn homeostasis in the etiology of PD.


Assuntos
Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Homeostase , Modelos Genéticos , Doença de Parkinson/genética , Doença de Parkinson/metabolismo , Sulfato de Zinco/farmacocinética , Animais , Disponibilidade Biológica , Biomarcadores/análise , Etilenodiaminas/análise , Etilenodiaminas/metabolismo , Etilenodiaminas/farmacocinética , Sulfato de Zinco/análise , Sulfato de Zinco/metabolismo
15.
Artigo em Inglês | MEDLINE | ID: mdl-30690156

RESUMO

The release of engineered nanoparticles in the aquatic environment could pose a threat to the biota. The purpose of the study was to examine the influence of surface water characteristics on zinc oxide nanoparticles (nZnO) and ZnS04 toxicity to the freshwater mussel Dreissena polymorpha. Mussels were exposed to an equivalent concentration of 25 µg/L Zn as either nZnO or ZnSO4 for 96 h at 15 °C in 4 types of surface waters: green water (high conductivity and pH with low natural organic matter content), brown water (low conductivity and pH with high natural organic matter content), diluted municipal effluent (high conductivity and pH with high urban organic matter content) and aquarium water (treated green water with organic matter removed). After the exposure period, mussels were analyzed for air-time survival, total and labile Zn levels in tissues, lipid metabolism (phospholipase A2, triglycerides levels) and oxidative stress (glutathione S-transferase, arachidonate cyclooxygenase, lipid peroxidation). The data revealed that mussels exposed to ZnSO4 in controlled aquarium water accumulated more total and labile Zn tissues, decreased oxidative stress and triglycerides and increased air time survival. While nZnO had few effects in aquarium water, oxidative stress was enhanced and total Zn in tissues were decreased in brown water and diluted municipal effluent and triglycerides were higher in nZn-exposed mussels in brown water. Air-time survival was decreased in mussels kept in green water and nZnO. It was also decreased in mussels exposed to ZnSO4 in green water and diluted municipal effluent. In conclusion, the fate and toxic effects of Zn could be influenced by both the chemical form (nanoparticles or ionic Zn) and surface water properties in freshwater mussels.


Assuntos
Dreissena/efeitos dos fármacos , Nanopartículas Metálicas/toxicidade , Óxido de Zinco/farmacocinética , Óxido de Zinco/toxicidade , Animais , Disponibilidade Biológica , Transporte Biológico , Biomarcadores , Poluentes Químicos da Água/farmacocinética , Poluentes Químicos da Água/toxicidade , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/toxicidade
16.
Neuroreport ; 19(10): 1063-6, 2008 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-18580580

RESUMO

Hypoxia-inducible factor-1 (HIF-1) regulates the expression of neuroprotective genes such as erythropoietin (EPO). We investigated the mechanism by which zinc, an excitotoxin-like metal, regulates HIF-1 under hypoxic conditions in astrocytes. In hypoxic LN215 cells, HIF-1alpha stabilized and accumulated in the nucleus, resulting in an increase in its DNA-binding activity to the EPO enhancer. Zinc inhibited hypoxia-induced increases in HIF-1 DNA-binding activity and the HIF-1-dependent mRNA expression of EPO. Zinc did not affect hypoxic stabilization of HIF-1alpha. Nuclear migration of HIF-1alpha upon hypoxia was reduced by zinc. Complete blockade of hypoxia-induced assembly of HIF-1alpha-HIF-1beta complex was observed after treatment of zinc. These findings suggest that zinc hampers hypoxia-stimulated HIF-1 activation in astrocytes by inhibiting nuclear HIF-1alpha translocation and subsequently disrupting HIF-1 heterodimerization.


Assuntos
Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Hipóxia/metabolismo , Sulfato de Zinco/farmacocinética , Antineoplásicos/farmacologia , Astrocitoma/patologia , Linhagem Celular Tumoral , Núcleo Celular/metabolismo , Relação Dose-Resposta a Droga , Interações Medicamentosas , Ensaio de Desvio de Mobilidade Eletroforética/métodos , Eritropoetina/genética , Eritropoetina/metabolismo , Humanos , Prolina/análogos & derivados , Prolina/farmacologia , Transporte Proteico/efeitos dos fármacos , Tiocarbamatos/farmacologia , Fatores de Tempo , Sulfato de Zinco/farmacologia
17.
Toxicol Lett ; 171(1-2): 10-8, 2007 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-17590543

RESUMO

The present study was performed to evaluate the efficacy of zinc treatment on colonic antioxidant defense system and histoarchitecture in 1,2-dimethylhydrazine- (DMH) induced colon carcinogenesis in male Sprague-Dawley rats. The rats were segregated into four groups viz., normal control, DMH treated, zinc treated, DMH+zinc treated. Colon carcinogenesis was induced through weekly subcutaneous injections of DMH (30 mg/kg body weight) for 16 weeks. Zinc (in the form of zinc sulphate) was supplemented to rats at a dose level of 227 mg/L in drinking water, ad libitum for the entire duration of the study. Increased tumor incidence, tumor size and number of aberrant crypt foci (ACF) were accompanied by a decrease in lipid peroxidation, glutathione-S-transferase, superoxide dismutase (SOD) and catalase. On the contrary, significantly increased levels of reduced glutathione (GSH) and glutathione reductase (GR) were observed in DMH treated rats. Administration of zinc to DMH treated rats significantly decreased the tumor incidence, tumor size and aberrant crypt foci number with simultaneous enhancement of lipid peroxidation, SOD, catalase and glutathione-S-transferase. Further, the levels of GSH and GR were also decreased following zinc supplementation to DMH treated rats. Well-differentiated signs of dysplasia were evident in colonic tissue sections by DMH administration alone. However, zinc treatment to DMH treated rats greatly restored normalcy in the colonic histoarchitecture, with no apparent signs of neoplasia. EDXRF studies revealed a significant decrease in tissue concentrations of zinc in the colon following DMH treatment, which upon zinc supplementation were recovered to near normal levels. In conclusion, the results of this study suggest that zinc has a positive beneficial effect against chemically induced colonic preneoplastic progression in rats induced by DMH.


Assuntos
Anticarcinógenos/uso terapêutico , Neoplasias do Colo/prevenção & controle , Sulfato de Zinco/uso terapêutico , 1,2-Dimetilidrazina/administração & dosagem , 1,2-Dimetilidrazina/toxicidade , Administração Oral , Alquilantes/administração & dosagem , Alquilantes/toxicidade , Animais , Anticarcinógenos/administração & dosagem , Anticarcinógenos/farmacocinética , Antioxidantes/metabolismo , Disponibilidade Biológica , Peso Corporal/efeitos dos fármacos , Carcinógenos/administração & dosagem , Carcinógenos/toxicidade , Catalase/metabolismo , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/patologia , Glutationa/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Injeções Subcutâneas , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/patologia , Lesões Pré-Cancerosas/prevenção & controle , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/farmacocinética
18.
Hell J Nucl Med ; 10(3): 167-71, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18084658

RESUMO

Hyperthyroidism in men is often treated with high doses of iodine-131 ((131)I), which may induce radiation side effects to patients and their environment. These therapeutic doses of (131)I could be decreased, if the (131)I uptake of the thyroid gland of the patients could be increased. Zinc sulphate has been considered to exercise a protective role by maintaining the cellular integrity of the thyroid under various pathological states. The aim of our study was to study in Wistar rats whether zinc sulphate can after treatment of the thyroid gland with (131)I: a) increase the uptake of (131)I in the thyroid and b) stabilize the function of the follicular cells. If such a stabilization finally exists in men we could have favorable results like fewer cases of hypothyroidism after (131)I treatment of hyperthyroidism. To carry out these investigations, rats were divided into four groups comprising of eight animals each. Group I animals served as normal controls. Group II animals received a dose of 3.7 MBq of (131)I. Group III animals were supplemented with zinc (227 mg/L of drinking water) and animals in Group IV were given (131)I together with zinc sulphate as above. Our results showed that in Group II, serum levels of tetra-iodo-thyronine (T(4)) and tri-iodo-thyronine (T(3)) decreased significantly as a function of time following (131)I treatment. An increase in the levels of serum thyroid stimulating hormone (TSH) was noticed one week after (131)I treatment, becoming less pronounced with time. In Group II, thyroid uptake at 2h and at 24h was significantly decreased. In the same Group biological half life (T(biol)) of (131)I in the thyroid gland, was significantly elevated four weeks after the administration of (131)I and decreased eight weeks after. In Group IV animals, zinc sulfate after four weeks, induced normalization of elevated serum TSH levels and a further increase in the T(biol) of (131)I. After eight weeks in these animals, serum T(3) became normal and TSH remained at normal levels. Thyroid (131)I uptake at 2 and 24 h was increased as compared to Group II. Group III animals showed some increase in the levels of Na(+)K(+)ATPase and type 1,5'-deiodinase (5'-DI) as compared to normal rats of Group I. In conclusion, this study suggests the protective potential of zinc sulphate in the disturbed after (131)I treatment, thyroid function, thyroid hormones and TSH while the (131)I uptake was reduced. Thus, if this result is further confirmed, zinc sulphate may show to be a promising radioprotective agent for the thyroid gland.


Assuntos
Radioisótopos do Iodo/administração & dosagem , Folículo Ovariano/efeitos dos fármacos , Glândula Tireoide/efeitos dos fármacos , Animais , Feminino , Hipotireoidismo/tratamento farmacológico , Hipotireoidismo/metabolismo , Hipotireoidismo/patologia , Iodeto Peroxidase/sangue , Radioisótopos do Iodo/farmacocinética , Radioisótopos do Iodo/uso terapêutico , Cinética , Folículo Ovariano/citologia , Folículo Ovariano/metabolismo , Ratos , Ratos Wistar , ATPase Trocadora de Sódio-Potássio/sangue , Testes de Função Tireóidea , Glândula Tireoide/metabolismo , Glândula Tireoide/patologia , Tiroxina/sangue , Tri-Iodotironina/sangue , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/uso terapêutico
19.
Indian J Exp Biol ; 44(9): 705-18, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16999025

RESUMO

During the last two decades Zinc (Zn) as a micronutrient is being used indiscriminately in agricultural and husbandry practices and also in baby foods and multivitamin supplements with a view that Zn is non-toxic and promotes linear growth and body weight in the consumers. The long-term effect of increasing Zn load in the body has not been worked out so far. In this study, three groups of rats were fed on a semi-synthetic diet containing 20 mg (control, group-I), 40 mg (group-II) and 80 mg Zn /kg (group-III) diet respectively for 6 months. The results revealed that the gain in body weight increased in rats in Zn-concentration dependent manner. The urine examined on weekly basis showed glucosuria in group-II on week 10 and in group-III on week 8 and thereafter. The arterial blood pressure was significantly higher in group-II and III than their control counter parts on monthly basis. Histochemical examination of skin revealed an increase in the number of adipocytes filled with triglycerides making a subcutaneous fatty tissue thicker in group-II and group-III than that of control group. The blood profile after 180 days of dietary treatment, displayed a significant rise in glucose, total lipids, cholesterol, triglycerides, LDL-cholesterol, VLDL-cholesterol, insulin, cortisol and aldosterone whereas HDL-cholesterol, T3, T4 and TSH showed a reduction in their levels in the blood serum. The tissue metal status showed an increase of Zn, Cu and Mg in the serum, a rise in Zn in liver, hair and abdominal muscles and fall in Cu and Mg concentrations in liver, hair and abdominal muscles. This data suggest that Zn in excess in diet when fed for longer periods of time induces metabolic syndrome-X.


Assuntos
Dieta , Gorduras na Dieta/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Síndrome Metabólica/induzido quimicamente , Sacarose/efeitos adversos , Sulfato de Zinco/efeitos adversos , Animais , Pressão Sanguínea/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Gorduras na Dieta/administração & dosagem , Masculino , Síndrome Metabólica/metabolismo , Síndrome Metabólica/fisiopatologia , Ratos , Ratos Wistar , Gordura Subcutânea/efeitos dos fármacos , Gordura Subcutânea/crescimento & desenvolvimento , Gordura Subcutânea/metabolismo , Sacarose/administração & dosagem , Fatores de Tempo , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/farmacocinética
20.
Environ Sci Pollut Res Int ; 23(10): 9669-78, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26846243

RESUMO

Nanoparticulate ZnO is one of the most commonly applied nanomaterials. As ZnO is more soluble than many other oxide nanoparticles, its toxicity beyond the nanoparticle-specific effects can be attributed to the dissolved ionic zinc. The investigation of uptake and toxicity of nano-ZnO in the plant-feeding nematode, Xiphinema vuittenezi, which was used in previous studies as a biological model organism, was aimed. The establishment of the role of dissolved zinc and nanoparticle-specific effects in the toxicity was also the objective of our study. Zn uptake was found to be significantly higher for bulk and nano-ZnO than for ZnSO4 solution; however, treatments caused loss of potassium in the worms in a dissolved-zinc-dependent manner. The toxicity was the lowest for bulk ZnO, and it was very similar for nano-ZnO and ZnSO4 solution. Accordingly, the toxicity of ZnO nanoparticles is a combination of dissolved-zinc-caused toxicity and nanoparticle-specific effects.


Assuntos
Nanopartículas Metálicas , Nematoides/química , Nematoides/metabolismo , Zinco , Animais , Nanopartículas Metálicas/química , Nanopartículas Metálicas/toxicidade , Zinco/química , Zinco/farmacocinética , Zinco/toxicidade , Sulfato de Zinco/química , Sulfato de Zinco/farmacocinética , Sulfato de Zinco/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA